Nurtec
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3201 Pinellas Pl, Tampa, Florida, 33619,...Website
www.nurtec.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nurtec
Nurtec is a pharmaceutical company founded in 2011 that specializes in developing and manufacturing treatments for migraines. The company's flagship product, Nurtec ODT, is a prescribed medication for both acute treatment and prevention of migraines in adults. This oral CGRP receptor antagonist is designed to provide rapid pain relief within 2 hours and can last up to 48 hours for many patients. Nurtec focuses on helping adults with episodic migraines reduce both the severity and frequency of migraine days, improving quality of life. The company operates primarily in North America and maintains a strong research and development division with scientific expertise in neurological pharmaceuticals.Explore more
Nurtec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nurtec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nurtec recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nurtec has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nurtec
Click to see if Nurtec had a recent Job posting/layoffs
Product Launch: Get notified when Nurtec launches new products
Check out if Nurtec is spiking on competitors!
Nurtec, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nurtec has new funding data
Recommended Actions
Find VP level buyers at Nurtec
Find more new buyers
Compare Similar Companies to Nurtec
Compare insights from companies similar to Nurtec, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nurtec is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nurtec is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nurtec.
Nurtec Tech Stack
A closer look at the technologies used by Nurtec
See more technologies
Nurtec News & Media
Biohaven Sets New Course with $258 Million in Cash, a Proven Team and Deep Pipeline to Continue its Journey to Advance Science for Patients
Broad therapeutic research and development portfolio includes more than 13 clinical and pre-clinical programs with a focus on neuroscience and rare disorders including epilepsy, pain and mood disorders, obsessive compulsive disorder (OCD), spinocerebellar ataxia (SCA) and spinal muscular...Biohaven Presents New Migraine Data at 64th Annual Scientific Meeting of the American Headache Society, including First of Its Kind Study for Nurtec® ODT (rimegepant), and Complete Phase 3 Data for Zavegepant Nasal Spray
- Nurtec ODT open-label extension study is the first of its kind evaluating a CGRP-targeted medication in patients who are using it as a preventive and an as-needed acute treatment for migraine - Over the course of this open-label extension study, > 80% of patients experienced ≥50%...Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven Record reported revenues of $319 million NURTEC® ODT (rimegepant) TRx volumes grew 8% versus the fourth quarter...Pfizer to Acquire Biohaven Pharmaceuticals
NEW YORK & NEW HAVEN, CONN.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults. Under the terms of the agreement, Pfizer will acquire all outstanding shares of Biohaven not alread
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nurtec
Sign Up For FreeTo access detailed company insights
Nurtec is a pharmaceutical company founded in 2011 that specializes in developing and manufacturing treatments for migraines. The company's flagship product, Nurtec ODT, is a prescribed medication for both acute treatment and prevention of migraines in adults. This oral CGRP receptor antagonist is designed to provide rapid pain relief within 2 hour... Read More
